Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.200 | None | 1.000 | 119 | 1 | 1994 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 53 | 0 | 1999 | 2020 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
disease | 0.100 | None | 1.000 | 51 | 2 | 1998 | 2020 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.100 | None | 1.000 | 45 | 1 | 2003 | 2019 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.300 | None | 1.000 | 41 | 2 | 2001 | 2019 | ||||||||
|
EPH receptor B2 | 0.374 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 38 | 1 | 2001 | 2019 | ||||||||
|
gastrin releasing peptide receptor | 0.595 | 0.538 | 0.22 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 1998 | 2020 | ||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
disease | 0.100 | None | 1.000 | 35 | 0 | 2010 | 2019 | |||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.100 | None | 1.000 | 34 | 6 | 1996 | 2019 | ||||||||
|
early growth response 1 | 0.433 | 0.923 | 0.35 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1998 | 2019 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 31 | 0 | 1997 | 2019 | ||||||||
|
collagen type XI alpha 2 chain | 0.435 | 0.846 | 0.70 |
|
disease | 0.100 | None | 1.000 | 30 | 0 | 2003 | 2019 | ||||||||
|
gastrin releasing peptide | 0.524 | 0.769 | 2.5E-03 |
|
disease | 0.100 | None | 1.000 | 29 | 0 | 1997 | 2020 | ||||||||
|
forkhead box A1 | 0.522 | 0.731 | 0.22 |
|
disease | 0.100 | None | 1.000 | 29 | 0 | 2009 | 2020 | ||||||||
|
kallikrein related peptidase 4 | 0.559 | 0.692 | 4.5E-06 |
|
disease | 0.100 | None | 1.000 | 29 | 0 | 2001 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.100 | None | 1.000 | 28 | 0 | 1995 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 27 | 0 | 1995 | 2019 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 2005 | 2019 | ||||||||
|
growth differentiation factor 15 | 0.429 | 0.808 | 3.0E-07 |
|
disease | 0.100 | None | 1.000 | 26 | 1 | 2003 | 2019 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
disease | 0.100 | None | 1.000 | 25 | 1 | 2001 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.100 | None | 1.000 | 25 | 7 | 2003 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 1.000 | 25 | 1 | 1993 | 2019 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
disease | 0.100 | None | 1.000 | 25 | 0 | 2008 | 2020 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.200 | None | 1.000 | 24 | 22 | 2005 | 2019 | |||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 24 | 6 | 2006 | 2019 |